Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

KMTS

Kestra Medical Technologies Ltd

Apr 01 • 04:00PM ET

24.58

Dollar change -0.34
Percentage change -1.36	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Held by: ONEQ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.89	Insider Own	60.77%	Shs Outstand	49.53M	Perf Week	-2.50%
Market Cap	1.22B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	19.43M	Perf Month	-
Income	-93.67M	PEG	-	EPS next Q	-0.60	Inst Own	-	Short Float	4.11%	Perf Quarter	-
Sales	45.82M	P/S	26.57	EPS this Y	-	Inst Trans	-94.98%	Short Ratio	1.62	Perf Half Y	-
Book/sh	-5.11	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.80M	Perf Year	-
Cash/sh	1.55	P/C	15.83	EPS next 5Y	-	ROE	-	52W Range	20.00 - 25.98	Perf YTD	12.55%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-127.16%	52W High	-5.39%	Beta	-
Dividend TTM	-	Quick Ratio	2.67	Sales past 5Y	264.53%	Gross Margin	26.86%	52W Low	22.90%	ATR (14)	2.05
Dividend Ex-Date	-	Current Ratio	2.81	EPS Y/Y TTM	-	Oper. Margin	-169.91%	RSI (14)	-	Volatility	8.69% -
Employees	-	Debt/Eq	1.67	Sales Y/Y TTM	-	Profit Margin	-204.41%	Recom	1.33	Target Price	27.67
Option/Short	No / Yes	LT Debt/Eq	1.67	EPS Q/Q	20.43%	Payout	-	Rel Volume	0.49	Prev Close	24.92
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	193.09%	Earnings	Jan 01	Avg Volume	492.18K	Price	24.58
SMA20	6.58%	SMA50	6.58%	SMA200	6.58%	Trades		Volume	246,263	Change	-1.36%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-31-25	Initiated	Wolfe Research	Outperform	$29
Mar-31-25	Initiated	Wells Fargo	Overweight	$28
Mar-31-25	Initiated	Stifel	Buy	$28
Mar-31-25	Initiated	Piper Sandler	Overweight	$27
Mar-31-25	Initiated	Goldman	Neutral	$24
Mar-31-25	Initiated	BofA Securities	Buy	$30

Mar-14-25 04:05PM	Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering (GlobeNewswire) +16.50%
Mar-07-25 05:30PM	Kestra Medical Technologies, Ltd. Announces Closing of Upsized Initial Public Offering (GlobeNewswire)
Mar-05-25 11:03PM	Kestra Medical Technologies, Ltd. Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)
Feb-26-25 08:00AM	Kestra Medical Technologies, Ltd. Announces Launch of Initial Public Offering (GlobeNewswire)

Kestra Medical Technologies Ltd. operates as a commercial-stage, wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company was founded by Brian Webster and Phillip D. Foshee in 2014 and is headquartered in Kirkland, WA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KMTS

Kestra Medical Technologies Ltd

Upgrade your FINVIZ experience